Daily interferon regimen for chronic hepatitis C. A prospective randomised study

Clinical Drug Investigation

Volumn 18, Issue 1, 1999, Pages 11-16

  Bruno, Raffaele ^a   Debiaggi, Maurizia ^a   Sacchi, Paolo ^a   Maffezzini, Elena ^a   Zara, Francesca ^a   Brunetti, Enrico ^a   Filice, Carlo ^a   Patruno, Savino F A ^a   Filice, Gaetano ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; LYMPHOBLAST INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; HAIR LOSS; HEADACHE; HEPATITIS C; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; THROMBOCYTOPENIA; VERTIGO; WEIGHT REDUCTION;

EID: 0032799683     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918010-00002     Document Type: Article

References (16)

1. 1. McHutchinson JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339 (21): 1485
2. 2. Hoofnagle JH, DiBisceglie AM. Drug therapy: the treatment of chronic viral hepatitis. N Engl J Med 1997; 336 (5): 347
3. 3. Saracco G, Rosina F, Torriani Cerenzia MR, et al. A randomised controlled trial of interferon alpha 2b as therapy for chronic non-A non-B hepatitis. J Hepatol 1990; 11: S43-49
4. 4. Marcellin P, Boyer N, Giostra E, et al. Recombinant human alpha Interferon in patients with chronic non-A non-B hepatitis: a multicenter randomised controlled trial from France. Hepatology 1991; 13: 393-7
5. 5. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomised controlled trial. N Engl J Med 1989; 321: 1506-10
6. 6. Poynard T, Bedossa P, Chevalier M, et al. A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A non-B hepatitis. N Engl J Med 1995; 332: 1457-62
7. 7. Neumann AU, Lam NP, Dehari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon α therapy. Science 1998; 282: 103-7
8. 8. Manzin A, Bagnarelli P, Menzo S, et al. Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol 1994; 32: 1939-44
9. 9. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995; 15: 70-81
10. 10. Orito E, Mizokami M, Suzuki K, et al. Loss of serum HCV-RNA at week 4 of interferon alpha therapy is associated with more favourable long term response in patients with chronic-hepatitis C. J Med Virol 1995; 46: 109-15
11. 11. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-32
12. 12. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV-RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-81
13. 13. Lau DT-Y, Kleiner DE, Ghany MG, et al. Sustained virologic response to interferon alpha (IFNα) in chronic hepatitis C is associated with long-term histologic improvement and lack of hepatic HCV-RNA [abstract]. Gastroenterology 1998; 114 Suppl.: A1284
14. 14. Gretch DR, Sullivan DG, Lam N, et al. Influence of therapeutic regimens on rates of HCV quasi-species diversification [abstract]. Hepatology 1998; 28 Suppl.: 939
15. 15. Farrell GC, Bacon BR, Goldin RD, et al. Lymphoblastoid interferon alpha n-1 improves the long-term response to a 6 month course of treatment in chronic hepatitis C compared with recombinant interferon alpha-2b: results of an international randomised controlled trial. Clinical advisory group for the hepatitis C comparative study. Hepatology 1998; 27 (4): 1121-7
16. 16. Bodenheimer Jr HC, Lindsay KL, Davis GL, et al. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1997; 26: 473-7